The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.22
Bid: 42.22
Ask: 42.34
Change: -0.12 (-0.28%)
Spread: 0.12 (0.284%)
Open: 41.72
High: 42.74
Low: 41.72
Prev. Close: 42.34
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

13 Jan 2020 07:00

RNS Number : 5048Z
Assura PLC
13 January 2020
 

13 January 2020

Assura plc

 

Trading Update

For the third quarter ending 31 December 2019

 

Continued strong performance

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the third quarter ending 31 December 2019.

 

Jonathan Murphy, CEO, said:

 

"Assura continued to make strong progress in the third quarter. We expanded our market-leading portfolio with the acquisition of six high-quality assets and completed our third development of the year in Stow-on-the-Wold. We also grew our immediate pipeline of acquisition and development opportunities, reinforcing what was already our strongest in 10 years, to £252 million including 13 developments currently on site."

 

"With the new Government enshrining in law increased funding for the NHS and taking forward the Health Infrastructure Plan, better primary care facilities for patients, staff and services are at the heart of the agenda. In this context, Assura is well positioned to deliver high-quality assets and value for money for the NHS."

 

Building the portfolio

·; Current portfolio of 563 properties.

·; Development completed at Stow-on-the-Wold, taking total to three completed year to date at a total cost of £11.8 million.

·; Currently on site with 13 developments at the period end with a total development cost of £66 million.

·; Six acquisitions completed in the period at a cost of £31.1 million; four disposals made for cash proceeds of £1.0 million.

 

Expanding the pipeline

·; Immediate development pipeline further increased to £90 million, up from £72 million at September 2019.

·; Immediate acquisitions pipeline further increased to £96 million, up from £65 million at September 2019.

·; Total immediate pipeline, including on site developments, worth £252 million, up from £206 million at September 2019.

 

Growing the rent roll

·; Five lease re-gears completed in the quarter taking cumulative year-to-date re-gears to 18. These leases represent £1.7 million of the Group's rent roll, adding a weighted average of 10.2 years WAULT to those 18 leases.

·; Annualised rent roll at £105.8 million taking account of additions, disposals and rent reviews.

 

Robust balance sheet

·; As at 31 December 2019 gross debt stood at £787 million with undrawn facilities of £280 million.

 

As previously announced, the quarterly dividend has been increased to 0.697 pence per share with effect from January 2020. This is equivalent to 2.788 pence per share on an annualised basis.

 

ENDS

 

 

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFO

David Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2019, Assura's property portfolio was valued at £2,039 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFERLEIILII
Date   Source Headline
15th Dec 20143:12 pmRNSAcquisition of three medical centres for £11.5m
3rd Dec 20147:00 amRNSAssura completes Kidderminster purchase agreement
2nd Dec 20143:22 pmRNSNotification of Major Interest In Shares
28th Nov 20144:40 pmRNSSecond Price Monitoring Extn
28th Nov 20144:35 pmRNSPrice Monitoring Extension
28th Nov 201410:05 amRNSTotal Voting Rights
27th Nov 20142:26 pmRNSConfirmation of Quarterly Interim Dividend
25th Nov 20147:00 amRNSInterim Results 2014
6th Nov 20147:00 amRNS£63m acquisition and £21m development agreement
3rd Nov 20143:47 pmRNSNotification of Major Interest in Shares
3rd Nov 201412:20 pmRNSNotification of Major Interest in Shares
3rd Nov 20147:00 amRNSAssura adds four new medical centres
22nd Oct 20145:42 pmRNSNotification of Major Interest in Shares
22nd Oct 20144:52 pmRNSNotification of Major Interest in Shares
22nd Oct 201410:23 amRNSNotification of Major Interest in Shares
20th Oct 20141:00 pmRNSNotification of Major Interest in Shares
17th Oct 20149:25 amRNSNotification of Major Interest in Shares
16th Oct 20145:37 pmRNSNotification of Major Interest in Shares
16th Oct 20145:32 pmRNSNotification of Major Interest in Shares
16th Oct 20141:29 pmRNSDirector/PDMR Shareholding
16th Oct 20141:29 pmRNSTR-1: Notification of Major Interest in Shares
16th Oct 201412:38 pmRNSNotification of Major Interest in Shares
15th Oct 20142:58 pmRNSConfirmation of Quarterly Interim Dividend
14th Oct 20143:36 pmRNSResult of Extraordinary General Meeting
14th Oct 20143:15 pmRNSNotification of Major Interest in Shares
13th Oct 20144:27 pmRNSTR-1: Notification of Major Interest in Shares
13th Oct 20142:54 pmRNSTR-1: Notification of Major Interest in Shares
10th Oct 20147:00 amRNSResult of Proposed Share Issue
30th Sep 20146:05 pmRNSTR-1: Notification of Major Interest In Shares
24th Sep 20141:56 pmRNSPublication of Prospectus
24th Sep 20147:00 amRNSProposed Share Issue and Notice of EGM
4th Sep 201411:46 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
21st Aug 20147:00 amRNSAcquisition and funding agreement
14th Aug 201411:14 amRNSNotification of Major Interest in Shares
13th Aug 20145:08 pmRNSNotification of Major Interest in Shares
31st Jul 20147:00 amRNSInterim Management Statement
23rd Jul 20147:00 amRNSAcquisition of Medical Centre
22nd Jul 20145:29 pmRNSAnnual Information Update
22nd Jul 20144:57 pmRNSResult of AGM
1st Jul 201412:16 pmRNSTotal Voting Rights and Issued Share Capital
1st Jul 20149:24 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
23rd Jun 20145:15 pmRNSNotification of Major Interest in Shares
20th Jun 20143:34 pmRNSAnnual Report & Notice of AGM
13th Jun 20147:00 amRNSAcquisition of 28 medical centres for £107 million
10th Jun 20149:44 amRNSConfirmation of Quarterly Interim Dividend
23rd May 20147:00 amRNSPreliminary results for year ended 31 March 2014
2nd Apr 201411:42 amRNSConfirmation of Quarterly Interim Dividend
4th Mar 201412:00 pmRNSDirector/PDMR Shareholding
14th Feb 20147:00 amRNSInterim Management Statement
13th Feb 201411:58 amRNSNotification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.